Skip to main content
. 2018 May 1;27(6):581–586. doi: 10.1002/pds.4402

Table 2.

Number and crude incidence rates of unspecified intestinal malabsorption and intestinal malabsorption events (Germany: ICD10: K90.4. K90.8. K90.9; Italy: ICD‐9 codes: 579.8 or 579.9) stratified by treatment at index date

Outcome Index Date Treatment Number of Events Person‐Year (PY) Unadjusted Incidence Rate *100,000 PY Lower 95% Confidence Limit Upper 95% Confidence Limit
Unspecified intestinal Malabsorptiona Olmesartan 1 32,041 3.12 0.44 22.16
Other ARBs 12 136,827 8.77 4.98 15.44
ACE‐i 10 431,139 2.32 1.25 4.31
Intestinal malabsorptionb Olmesartan 4 32,035 12.49 4.69 33.27
Other ARBs 20 136,818 14.62 9.43 22.66
ACE‐i 39 431,123 9.05 6.61 12.38

ACE‐i indicates angiotensin converting enzyme inhibitor; ARB, angiotensin II receptor blocker.

a

ICD‐10: K90.4, K90.8, K90.9; ICD‐9:579.8, 579.9.

b

ICD‐10: K90.x; ICD‐9: 579.x.